Adult 0.2 mL/kg IV. Angiography May administer 2nd inj if necessary. Confirmation of isolated metastasis or detection of leptomeningeal tumours 2nd inj of 0.4 mL/kg can be administered. MRI Neonate up to 4 wk, infant up to 1 yr & severe renal impairment (GFR <30 mL/min/1.73 m2) Not to exceed 0.1 mmol/kg & not to be repeated unless w/ at least 7-days interval.
Discontinue use if hypersensitivity reactions occur. Not to be inj intrathecally. History of allergy (eg, seafood allergy, hay fever, hives), sensitivity to contrast media, asthma. Increased risk for nephrogenic systemic fibrosis. Patients on β-blockers & w/ bronchial asthma; CV disease; low seizure threshold. Screen patients for renal dysfunction prior to initiation. May affect ability to drive & use machines. Peri-op liver transplant patients. Acute or chronic severe renal insufficiency. Not to be used during pregnancy. Lactation. Not recommended for angiography in childn <18 yr. Neonates <4 wk & infants up to 1 yr. Elderly ≥65 yr.
Sign Out
